Plozalizumab
Product Specifications
CAS Number
1610761-46-0
Target
CCR
Related Pathways
Microbiology/Virology, GPCR/G Protein, Immunology/Inflammation
Purity
0.988
Bioactivity
Plozalizumab (MLN-1202) is a humanized, selective, and potent anti-CCR2 antibody with antitumor activity, used in the study of malignant melanoma.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog